Human transforming growth factor beta 2 mRNA (TGFB2 mRNA) (TGFB2 mRNA)

Human transforming growth factor beta 2 (TGF-β2) mRNA is the messenger RNA transcript that encodes the TGF-β2 protein, a member of the TGF-beta superfamily involved in regulating cell growth, differentiation, and immune function (UniProt P61812). In various malignancies, such as glioblastoma and pancreatic cancer, the overexpression of this mRNA leads to high levels of TGF-β2 protein, which functions as a potent immunosuppressor and driver of the epithelial-mesenchymal transition (Bogdahn et al., 2011). This makes the mRNA a strategic therapeutic target for antisense oligonucleotides (ASOs), which are designed to bind to the transcript and prevent the synthesis of the pathological protein (Schlingensiepen et al., 2006). Drugs like Trabedersen (AP 12009) specifically target the human TGF-β2 mRNA to downregulate its expression, aiming to reverse tumor-mediated immune evasion and inhibit metastasis. Beyond oncology, targeting this mRNA is also explored in ophthalmology to prevent scarring and fibrosis following glaucoma filtration surgery (Isarna Therapeutics, 2023). The primary therapeutic challenge involves the efficient delivery of these large, negatively charged molecules to the intracellular environment, particularly across the blood-brain barrier for CNS indications. Additionally, because TGF-β signaling is pleiotropic, precise targeting is required to avoid interfering with the homeostatic functions of other TGF-β isoforms.

Other names

TGF-beta-2 mRNATGFB2 transcriptTransforming growth factor beta-2 mRNAAP 12009 targetTrabedersen target

Antisense oligonucleotide-mediated inhibition of translation and RNase H-dependent mRNA degradation (Schlingensiepen et al., 2006).